Skip to main content

Peer Review reports

From: Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study

Original Submission
6 Feb 2024 Submitted Original manuscript
16 Mar 2024 Reviewed Reviewer Report
31 Mar 2024 Reviewed Reviewer Report
24 Apr 2024 Author responded Author comments - Zhi-Qiang Li
18 May 2024 Reviewed Reviewer Report - Claudia Sabato
25 May 2024 Author responded Author comments - Zhi-Qiang Li
Resubmission - Version 2
24 Apr 2024 Submitted Manuscript version 2
27 May 2024 Author responded Author comments - Zhi-Qiang Li
Resubmission - Version 3
27 May 2024 Submitted Manuscript version 3
Publishing
28 May 2024 Editorially accepted
6 Jun 2024 Article published 10.1186/s12885-024-12441-0

You can find further information about peer review here.

Back to article page